+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Theravance Biopharma - logo

Theravance Biopharma is a biopharmaceutical company that develops and commercializes human therapeutics. The company offers VIBATIV (telavancin), a bactericidal, once-daily injectable antibiotic. In addition, it has numerous product candidates, including Revefenacin (TD-4208), Axelopran, Velusetrag, TD-6450 and others. It also focuses on various drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. Founded in 2013, it is based in George Town, the Cayman Islands.

From
Beta Receptor Agonist - Pipeline Insight, 2025 - Product Thumbnail Image

Beta Receptor Agonist - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 120 Pages
  • Global
From
From
Multidrug Resistant Bacteria Market Report 2025 - Product Thumbnail Image

Multidrug Resistant Bacteria Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Gastroparesis - Pipeline Insight, 2025 - Product Thumbnail Image

Gastroparesis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Crohn's Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Crohn's Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 240 Pages
  • Global
From
From
From
Adrenergic Uptake Inhibitors - Pipeline Insight, 2025 - Product Thumbnail Image

Adrenergic Uptake Inhibitors - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
JAK inhibitors - Competitive Landscape, 2023 - Product Thumbnail Image

JAK inhibitors - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
Dysautonomia Or Autonomic Dysfunction - Pipeline Insight, 2025 - Product Thumbnail Image

Dysautonomia Or Autonomic Dysfunction - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Loading Indicator